These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1666 related items for PubMed ID: 18835834

  • 1. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program.
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [Abstract] [Full Text] [Related]

  • 2. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Nov; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 3. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ, GVHD Working Committee of Center for International Blood and Marrow Transplant Research.
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [Abstract] [Full Text] [Related]

  • 4. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.
    N Engl J Med; 2004 Nov 25; 351(22):2265-75. PubMed ID: 15564543
    [Abstract] [Full Text] [Related]

  • 5. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Nov 25; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 6. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, Hatanaka K, Tanimoto M, Harada M, Nakao S, Abe Y, Wake A, Eto T, Takemoto Y, Imamura M, Takahashi S, Ishida Y, Kanda Y, Kasai M, Takaue Y.
    Br J Haematol; 2005 Aug 25; 130(4):575-87. PubMed ID: 16098073
    [Abstract] [Full Text] [Related]

  • 7. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N, Traineau R, Houssin S, Peffault de Latour R, Petropoulou A, Robin M, Larghero J, Ribaud P, Socié G.
    Biol Blood Marrow Transplant; 2010 Sep 25; 16(9):1315-23. PubMed ID: 20353831
    [Abstract] [Full Text] [Related]

  • 8. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmür J, Gratwohl A, Seebach JD.
    Bone Marrow Transplant; 2002 Jul 25; 30(2):87-93. PubMed ID: 12132047
    [Abstract] [Full Text] [Related]

  • 9. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
    Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J.
    Bone Marrow Transplant; 1995 Jun 25; 15(6):853-8. PubMed ID: 7581080
    [Abstract] [Full Text] [Related]

  • 10. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L, Giralt S, Chan KW, Feig S, Territo M, Andersson B, van Besien K, Khouri I, Fischer H, Babbitt L, Ippolitti C, Schiller G, Lill M, Warkentin D, Neumann J, Petz L, Terasaki P, Champlin R.
    Biol Blood Marrow Transplant; 1997 Jun 25; 3(2):76-82. PubMed ID: 9267667
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.
    Mehta J, Singhal S, Gee AP, Chiang KY, Godder K, Rhee Fv Fv, DeRienzo S, O'Neal W, Lamb L, Henslee-Downey PJ.
    Bone Marrow Transplant; 2004 Feb 25; 33(4):389-96. PubMed ID: 14716338
    [Abstract] [Full Text] [Related]

  • 12. ABO-incompatible bone marrow transplantation.
    Wiesneth M, Hertenstein B, Bunjes D, Schmeiser T, Maccari B, Northoff H, Laasch H, Heit W, Arnold R, Heimpel H.
    Beitr Infusionsther; 1992 Feb 25; 30():354-8. PubMed ID: 1284733
    [Abstract] [Full Text] [Related]

  • 13. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb 25; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 14. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT.
    Transplant Proc; 2009 Nov 25; 41(9):3851-8. PubMed ID: 19917400
    [Abstract] [Full Text] [Related]

  • 15. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
    Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E.
    N Engl J Med; 2000 Jun 22; 342(25):1846-54. PubMed ID: 10861319
    [Abstract] [Full Text] [Related]

  • 16. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C, Muñiz-Díaz E, Martínez C, Martino R, Moreno I, Ramos A, Arilla M, Boto N, Pastoret C, Remacha A, Sierra J, Madoz P.
    Transfusion; 2004 Nov 22; 44(11):1603-11. PubMed ID: 15504166
    [Abstract] [Full Text] [Related]

  • 17. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug 22; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 18. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ.
    N Engl J Med; 1996 Feb 01; 334(5):281-5. PubMed ID: 8532022
    [Abstract] [Full Text] [Related]

  • 19. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kröger N, Schattenberg A, Schönland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D, Myeloma Subcommittee of the EBMT.
    Haematologica; 2007 Nov 01; 92(11):1513-8. PubMed ID: 18024400
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep 01; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.